The aim of this work was to study the feasi bility and reproducibility of in vivo measurement of ben zodiazepine receptors with single photon emission com puterized tomography (SPECT) in the baboon brain. Ar terial and brain regional activities were measured for 420 min in three baboons after single bolus injection of the benzodiazepine antagonist [1 2 3I]iomazenil. Data were fit to a three-compartment model to derive the regional bind ing potential (BP), which corresponds to the product of the receptor density, (B m aJ and affinity (l/Kd. Regional BP values (from 114 in striatum to 241 in occipital) were in good agreement with values predicted from in vitro studies. Constraining the regional volume of distribution of the nondisplaceable compartment to the value mea sured during tracer constant infusion experiments in ba-
Since the recent introduction of high affinity io dinated ligands and high resolution, brain dedicated, single photon emission computerized to mography (SPECT) devices, SPECT has been used to visualize various neuroreceptors in the brain, in cluding acetylcholine muscarinic receptors (Eckel man et al. , 1985) , dopamine D 2 receptors (Kung et boons (Larue lie et al., 1993) improved the identifiability of the rate constants. Each experiment was repeated to investigate the reproducibility of the measurement. The regional average reproducibility was 10 ± 5%, expressed as coefficient of variation (CV). Results of equilibrium analysis at peak uptake were in good agreement with re sults of kinetic analysis. Empirical counts ratio methods were found to be poorly sensitive to benzodiazepine re ceptor density. These studies suggest the feasibility of quantitative measurement of benzodiazepine receptors by kinetic analysis of SPECT data and the inadequacy of empirical methods of analysis, such as counts ratios, to evaluate differences in receptor density. Key Words: SPECT -Benzodiazepine receptors-Tracer kinetic model-[1 2 3I]iomazenil. Kung et aI., 1990; Chumpradit et al. , 1993) , dopamine and serotonin transporters (Neu meyer et al. , 1991; Shaya et al., 1992) , and benzo diazepine receptors (Beer et al., 1990; Innis et al. , 1991a) . Quantitative analysis of these SPECT im ages has been generally limited to empirical meth ods such as ratios of activity in a region of interest (ROI) to the activity in a region of reference. How ever, the ability of these empirical methods to pro vide accurate information about the receptors den sity is questionable and needs to be validated by model-based methods (Carson, 1991) . lomazenil (Ro 16-0154) is a high affinity benzodi azepine antagonist (Beer et al. , 1990) . Labeled with 1 23 1, it has been used as a SPECT radiotracer to visualize benzodiazepine receptors in human (Woods et al., 1992) and nonhuman primates (Innis et al. , 1991a) . e 23 1]iomazenil has high brain up take-peak uptake close to 10% of the injected dose (Zoghbi et aI., 1992) -and high specific binding �90% of the brain activity is displaceable by ben zodiazepine receptor agents (Innis et aI. , 1991 b) .
The goal of this study was to derive quantitative information about benzodiazepine receptors with e 23 I]iomazenil and SPECT, using model-based methods. Model-based methods for in vivo quanti fication of neuroreceptors as developed for positron emission tomography (PET) imaging can be broadly divided into kinetic and equilibrium methods. Ben zodiazepine receptors have been measured with [ l I C]flumazenil (Ro 15-1788) and PET by both ki netic (Holthoff et aI., 1991; Koeppe et aI. , 1991; Price et aI. , 1993) and equilibrium methods (Pappata et aI., 1988; Savic et aI., 1988; Iyo et aI. , 1991) . The kinetic method yields quantitative information about the receptors from the estimation of rate con stants that characterize the transfer between plasma, brain, and receptor compartments (Mintun et aI., 1984) . The equilibrium method derives this information from analysis of the activity distribu tion at equilibrium, i. e., when receptor-ligand asso ciation and dissociation rates are equal (Farde et aI., 1986) . When experiments are performed at tracer doses, these methods provide an estimation of the receptor binding potential (BP) (unitless) (Mintun et aI., 1982) , which is the ratio of the re ceptor density, B m a x (nM) to the equilibrium disso ciation constant, KD (nM).
In the present article, we report the determina tion of benzodiazepine receptor BP by kinetic anal ysis of regional time activity curves measured with SPECT after single bolus injection of tracer doses of high specific activity e 23 I]iomazenil in three ba boons (Papio anubis). Each experiment was per formed twice. Different kinetic models and fitting strategies were implemented and compared in terms of goodness of fit, parameter identifiability, sensi tivity to length of experiment, reproducibility, and accordance with in vitro measurements. In addi tion, the feasibility and accuracy of equilibrium and empirical ratio methods after single bolus tracer in jection were evaluated. In a companion paper in this issue (Laruelle et aI., 1994) , we report the re sults of equilibrium analysis of constant infusion ex periments in these three animals. At the end of these studies, in vitro homogenate binding experi ments were performed on the brain of two of these baboons to control the accuracy of SPECT in vivo measurements of benzodiazepine receptors.
THEORY

Three-compartment model
The time course of e 23 I]iomazenil brain uptake was first analyzed according to a three-compart-J Cereb Blood Flow Metab, Vol. 14, No.3, 1994 ment kinetic model ( Fig. lA, model 1) , which in cluded the arterial plasma compartment concentra tion (CJ, the intracerebral nondisplaceable com partment concentration (C2 ), and the specifically bound compartment concentration (C 3 ) . In both Ca and C 2 , the tracer could be either free (unbound) or nonspecifically bound, with f 1 and f 2 being the free fraction in C 1 and C 2 , respectively (Mintun et aI., 1984) .
The total concentration in an ROI, CRO l ( t ) , was given by
where Cv a s c ( t ) was the amount of radioactivity present in the vasculature within the ROl. If this quantity was negligible or has been subtracted, Eq. 1 became
(2) The apparent regional distribution volume at time t , V a ( t ) (ml of plasma/g of brain tissue) was the ratio of the total tracer concentration in the ROI to the concentration of the free tracer in the plasma at time t . The equilibrium volume of distribution of a compartment i, Vi (ml/g), was defined as the ratio of the tracer concentration in compartment i to the free tracer in the arterial plasma at equilibrium, i. e. , when no net transfer occurs between the plasma and this compartment
FIG. 1. Two-and three-compartment models used for analy sis of control experiments A: Three-compartment model: Ca is the tracer total concentration in arterial plasma; C 2 is the intracerebral tracer concentration-free and nonspecifically bound; C 3 is the concentration of the tracer bound to the receptor; K 1 is the rate of clearance from the plasma to the brain (ml 9-1 min-1 ); and k 2 -k4 are rate constants (min-1 ). B: Two-compartment model: the brain is considered as one compartment that includes free, nonspecifically bound, and specifically bound radi otracer (C 2 '). K 1 ' is equivalent to K 1 in model 1 while k 2 ' = k 2 / (1 + kJk4). V2 and V 3 were the equilibrium distribution volumes of the nondisplaceable and receptor compartments, respectively. V T was the total tissue equilibrium volume of distribution, equal to the sum of V2 and V 3 • The tracer concentration over time within the compartments was given by (Sandberg, 1978) as
where the kinetic parameters K l to k4 were defined as
where F was the regional blood blow (ml . g -1 min -1), E was the unidirectional extraction frac tion, PS was the permeability surface area product of the tracer (ml . g -1 min -1), kon was the bimolec ular ligand-receptor association rate constant (min -1 mM -1), Bm a x ' was the concentration of re ceptors available for binding (equal to Bm a x since experiments were performed at tracer doses), and koff was the receptor dissociation rate constant (min-I ).
The relationship between V2 and the kinetic pa rameters K l and k 2 (Eq. 7) was derived from Eq. 4 by setting k 3 ' k4' and the derivatives to zero.
Similarly, setting the derivatives in Eq. 5 to zero and substituting with Eq. 2 and 7 gave
Substituting in Eq. 11 the terms K l /k:! I ' k 3 ' and k4 with Eqs. 8, 9, and 10, respectively, and recalling that KD is equal to koalkon' established the equiva lence between V 3 and BP. V T was given by the sum of Eqs. 10 and 11
Simplification to a two-compartment model (12) Koeppe et al. (1991) showed that brain uptake of [ II C]flumazenil in the presence of receptors could be described with a two-compartment model (Fig. lB) . The brain concentration, C2 ', is now the sum of the free, the nonspecific ally bound, and the specif ically bound tracer. This configuration will be re ferred to as model 2. The equilibrium volume of distribution of the brain according to model 2, Vr ' , is calculated as 13) where K I ' and k 2 ' are the fractional rate constants describing the rate of transfer into and out of the brain. The relationship between the rate constants in models 1 and 2 are given by comparing Eqs. 12 and 13
(15) Equilibrium analysis of the two-compartment model After single bolus injection of the tracer, two equilibrium methods have been described for direct measurement of V T ' referred to here as the transient (Pappata et aI. , 1988) and peak equilibrium methods (Farde et aI., 1986) . We followed Carson et al. (1992) by using the term transient equilibrium to designate the method that relies upon the measure of V a ( t ) when this value becomes constant (i.e. , when brain and plasma activity are decreasing at the same rate). After single bolus injection of a re versible ligand, V a ( t ) reaches a constant value pro viding that An is smaller than the smallest eigen value, ai' of the brain impulse response function (Patlak et aI. , 1983) . The terms quasiequilibrium (Pappata et aI. , 1988) or pseudoequilibrium (Iyo et aI. , 1991) have also been used to designate the tran sient equilibrium method.
In contrast, the peak equilibrium method relies upon the measure of VT at peak regional uptake. At that single time point, there is no net transfer into or out of the region, and the ratio of the brain to plasma activity, Vp k ' is theoretically equal to VT •
METHODS
Radiolabeling
[1 2 3I]Iomazenil was labeled as previously described (Zoghbi et aI., 1992; Zea-Ponce et aI., 1993) . Briefly [1 2 3IHomazenil was prepared by iododestannylation of ethyl 7 -(tributylstannyl)-5 ,6-dihydro-5-methyl-6-oxo-4H imidazol[l ,5-a][1 ,4]benzodiazepine-3-carboxylate with chloramine-T in methanolic acetic acid at 120°C. The rlj. diolabeled product was purified by reversed phase HPLC (C-18 column, 3.9 x 300 mm, 55% CH30H/H20; 0.7 mIl min; Rt 9.2 min), formulated in normal saline containing 5% ethanol and 0.1 mM L-ascorbic acid, pH 5-6, and fil-tered through a 0.2 fL membrane filter. The radiochemical yield averaged 62.6 ± 3.3% (with this value and subse quent values expressed as mean ± SD) and the radio chemical purity averaged 97.0 ± 1.9%. For no-carrier added preparations, the specific activity was previously estimated by ultraviolet (UV) detection of the HPLC to be on the order of 180,000 Cilmmol (McBride et aI., 1991) . Provided that the experiments are performed under tracer conditions, the outcome measures used in the analyses presented here (rate constants and volumes of distribu tion) are independent of the specific activity.
Data acquisition
SPECT scanning experiments (n = 6) were performed in three female baboons, weighing 10-12 kg each, accord ing to protocols approved by the local animal care com mittee. Successive experiments in the same animal were separated by at least 2 weeks to allow recovery from the blood sampling (35 ml per experiment). Two experiments were performed on each baboon. The delay between ex periments 1 and 2 was 21, 202, and 16 days for baboons 1, 2, and 3, respectively.
Fasted animals were immobilized with ketamine (IO mg/kg, i.m.) and then anesthetized with 2.5% isoflurane via an endotracheal tube. Glycopyrrolate (10 fLg/kg, i.m.), a long-acting peripheral anticholinergic drug known not to cross the blood-brain barrier (Proakis and Harris, 1978) , was administered at the beginning of the study to de crease respiratory and digestive secretions. Vital signs were monitored every 30 min and the temperature kept constant at 37 ± OSC with heated water blankets. An i. v.
infusion line with 0.9% NaCI was maintained during each experiment and used for the injection of radiotracer. Two fiducial markers filled with 8 fLCi [99 m TclNaTc04 were glued onto each side of the baboon's head at the level of the cantho-meatal line. The baboon's head was immobi lized within the gantry using a "bean bag", which hard ens on evacuation (Olympic Medical, Seattle, WA, U.S.A.). e 2 31]1omazenil was administered i. v. over 30 s. The injected dose was 8.2 ± 0.5 mCi. Data were acquired with the CERASPECT camera (Digital Scintigraphics, Cam bridge, MA, U.S.A.) (Holman et aI., 1990) . The CERASPECT camera is a multi slice brain-dedicated de vice consisting of a stationary single annular crystal sur rounding three rotating parallel hole collimators. The in plane resolution of a point source in air is 7.7 mm full width at half maximum (FWHM) and the axial resolution in air is 5.9 mm FWHM (Zubal et aI., 1990) . The resolu tion of a point source in scattering milieu is 10-12 mm FWHM in all three planes. Scans were acquired in con tinuous mode for 2 min throughout the experiments. Ex periments lasted 420 min (n = 3) or 300 min (n = 3).
Arterial blood samples (0.5 m!) were collected with a peristaltic pump (Harvard, South Natick, MA, U.S.A.) every 20 s for the first 2 min of each experiment. Addi tional samples (1 m!) were drawn manually at 3, 4, 6, 8, 12, 16, 20, 30, 45 , and 60 min, then every 30 min until the end of the experiment. Blood samples were analyzed as previously described (Zoghbi et aI., 1992) . Activity was corrected for metabolites, using ethyl acetate extraction followed by reverse phase HPLC. Plasma protein binding was measured in vitro by ultracentrifugation through four Centrifree membrane filters (Amicon, Beverly, MA, U.S.A.). The parent compound free fraction'!I' was cal culated as the ratio of the filtrate concentration to the J Cereb Blood Flow Metab, Vol. 14, No.3, 1994 total concentration. Ca(t) was fit to a sum of n exponen tials n
where Co was the zero-time intercept of each exponential (fLCi/L), :md Ai was the elimination rate constant associ ated with each exponential (min -I ) . The terminal half-life was given by In(2)/An, where An was the smallest elimina tion rate constant. The initial volume of distribution of the tracer, Vbo1 (L), was given by the ratio of the injected dose, D (fLCi), to the peak plasma concentration, Co (fLCi/ L). The fraction of zero-time intercept associated with each exponential, fo, were given by Co/Co and the clearance, C L (Llmin) was calculated as .
(17)
Data analysis
Images were reconstructed from photopeak events (159 ± 15.9 keY) with a Butterworth filter (cutoff = 10 mm, power factor = 10). Images were displayed on a 64 x 64
x 32 matrix (pixel size = 3.3 mm x 3.3 mm, slice thick ness = 3.3 mm, voxel volume = 36.7 mm3). Attenuation correction was performed assuming uniform attenuation equal to that of water (attenuation coefficient fL = 0.150 cm 2 /g) within an ellipse drawn around the skull. Images were reoriented in three dimensions such that the can tho meatal plane, identified by the fiducial markers, corre sponded to the transaxial plane of the data set. The level of highest occipital activity was identified by visual in spection of the 32 images of the acquisition obtained 120 min postinjection. This level was invariably located three to four images above the canthomeatal plane. Five im ages, including three below and one above the level of maximal occipital activity, were then summed. Standard ROI profiles were positioned on the summed image. These ROls were defined in reference to an atlas of the baboon brain (Riche et aI., 1988) and to magnetic reso nance imaging (MRI) coregistered F 2 3Ijiomazenii SPECT images obtained in one baboon (Malison et al., 1992) . Investigated ROIs were the occipital (885 mm 2 ), right and left temporal (442 mm 2 each), frontal (132 mm 2 ), striatal (381 mm 2 ), and thalamic (171 mm 2 ).
Average cpm/ml for each ROI were transformed to fLCi/ml using a calibration factor (0.0069 fLCilcpm) mea sured with a 13.5 cm diameter distributed source filed with 854 ml of 0.2 fLCi/ml solution of 1 2 31, acquired and reconstructed using the same protocol. An ROI was also placed on a fiducial marker to control for the absence of movement throughout the experiment. No attempts were made to correct for partial volume effects nor for the scatter fraction of the photopeak window. Deadtime losses were estimated from the acquisition total counts over the entire energy spectrum (35-250 keY). 'ROI ac tivities were corrected for deadtime losses when needed, according to values established with a 20 cm diameter cylinder filled with F 2 3Il and allowed to decay from 5 to 0.1 mCi. The deadtime correction factor was not> 1.25 in these studies.
Previous experiments (Zoghbi et al., 1992) showed that p 2 3J]iomazenil concentrates equally in plasma and red blood cells and that 39% of the total blood activity is within red blood cells, a value similar to the hematocrit index. The contribution of the activity in the blood ves sels, C Y asc' to the total ROJ activity, CROI' was thus es timated using the total plasma activity integrated over the acquisition time and a mean blood volume value equal to 5% of the corresponding ROJ volume as measured in the baboon by Mintun et al. (1984) . The vascular contribution to total ROJ activity was <0.3% and was considered neg ligible.
Rate constants for arterial clearance and brain uptake of the tracer were estimated by nonlinear regression using a Levenberg-Marquart least-squares minimization proce dure (Levenberg, 1944) implemented in MA TLAB (The Math Works, Inc., South Natick, MA, U.S.A.) on a Mac intosh Quadra 950. Equation 2 was solved analytically as the convolution of the input function, Ca(t), by the im pulse response function, which was a sum of n exponen tials
where (Xi and Ai were functions of the rate constants (Phelps et al., 1979) and the number of exponentials, n, was equal to the number of compartments observed in the region of interest (Godfrey, 1983) .
Metabolite-corrected, fitted arterial tracer concentra tion values were used as input function (Logan et aI., 1987) . Input function values were calculated every 10 s for the first 2 min and every 2 min thereafter for the remainder of the experiment according to the parameters provided by fitting measured values to Eq. 16. Values prior to the peak plasma activity were calculated by linear interpolation. Preliminary exploration of the model showed that using denser input functions did not change the results of the optimization procedure.
Three fitting strategies were used (Table 1 , methods A-C). Method A corresponded to an unconstrained three compartment model ( Fig. lA , model 1) with four param eters to be estimated by the regression (KI-k4). Method B was performed according to the same model, except that the value of K,/k 2 was constrained, leaving only three parameters to be estimated by the regression (K" k 3 , k4). As both K, and k 2 include the regional blood flow (Eqs. 6 and 7), this constraint was not a constraint on the flow value but on the equilibrium distribution volume of the nondisplaceable compartment, V 2 , (Eq. 10). Method C corresponded to the two-compartment configuration (Fig.
IB, model 2).
Statistical differences in model parameters were tested with general linear modeling analysis of variance (ANOV A). Particular configurations of the ANOV A models are indicated in the results section (dependent variable: ANOV A, factor x factor; p values) with exact p values provided unless p < 0.01.
Several criteria were used to assess the quality of the methods:
(a) Goodness-oj-fit. Goodness-of-fit of models with dif ferent levels of complexity were compared using the Akaike Information Criterion (AIC) (Akaike, 1974) , and the F-test (Landlaw and DiStefano, 1984) .
(b) Parameter identifiability. The standard error of the parameters was given by the diagonal of the covariance matrix (Carson, 1986) and expressed as % of the param eters, coefficient of variation, (%CV).
(c) Stability over time. The stability over time of the outcome measures was assessed by fitting each model to data corresponding to increasing lengths of experiment (from 0-25 min to 0-400 min postinjection) and expressing the outcome measure in percentage of the final value (420 min).
(d) Reproducibility. The reproducibility of the outcome measures in experiment 2 as compared to experiment 1 was estimated by the SD of the measurements around the mean of the two experiments, expressed as percentage of the mean (%CV). Thus, both identifiability, i.e., how well this parameter is identifiable by the regression process, and reproducibility, i.e., how well this outcome measure was reproducible in experiment 2 as compared to exper iment I, were expressed as %CV.
(e) Comparison with in vitro values. Measured values of K, were compared to values expected from the phys icochemical properties of [' 2 3I]iomazenil. Values of BP were compared to values obtained in in vitro homogenate binding and autoradiography studies.
RESULTS
Plasma analysis
As previously reported, [ 1 23 l]iomazenil under went extensive metabolism into two classes of me tabolites (extractable and nonextractable in ethyl acetate) (Zoghbi et al. , 1992) . At the end of the ex periments, only 20-30% of the plasma activity rep resented parent compound. By both AlC criteria and F-test, a sum of three exponentials was selected to fit the plasma data (Fig. 2 ). Peak plasma activity was measured at 40-60 s in all experiments.
Mean ± SD values of ii' V bol' C v and terminal half lives for each animal were compared ( Table 2) . The I I and Vbol values were identical in all three baboons. In contrast, CL values showed significant differences between baboons, with baboon 1 show ing a faster CL (33 ± 3.2 Llh) than baboons 2 and 3 (21 ± 2 and 22 ± 1 Llh, respectively; ANOY A, p < 0.01).
Kinetic analysis of brain regional uptake
The occipital ROI showed the highest uptake, peaking at 100--120 min. Other investigated regions peaked earlier and at lower values (in decreasing order: temporal = frontal> striatum = thalamus).
Me t hod A. Regional time activity curves were first fit to an unconstrained three-compartment model (Table 3) . K I was reasonably well identified, with %CY ranging from 5.7 ± 1. 9 (striatum) to 12. 9 ± 5.0% (frontal ROI). Values of k 2 were more dis persed, with %CY ranging from 18 ± 7 (striatum) to 56 ± 42% (frontal). According to the model, k 3 ' which includes the Bm a x (Eq. 8), should vary among regions according to the relative densities of benzo diazepine receptors, whereas k4' which is equal to k O ff' should be constant across regions. As ex pected, k 3 varied from region to region, but the highest k 3 values were found in the frontal region, and the rank order of regional k 3 values were not correlated with relative density of receptors across these regions as measured by in vitro autoradiogra phy (occipital> temporal = frontal> striatum = thalamus) (Sybirska et aI. , 1992) . The k 3 values were affected with high %CY, ranging from 15 ± 6 (striatum) to 37 ± 32% (frontal). The k4 values were more stable across regions. The %CYs of k4 were lower than those of k 3 and k 2 ' with values ranging J Cereb Blood Flow Metab. Vol. 14, No. 3, 1994 from 5 ± 2 (striatum) to 17 ± 15% (frontal). Thus, the unconstrained fit provided reasonable identifi cation of K I and k4 but poor identification of k 2 and k 3 · Values of BP ranged from 235 ± 27 (occipital) to 92 ± 23 (striatum) and 94 ± 21 (thalamus), with the temporal and frontal regions showing intermediate values (151 ± 19 and 152 ± 23, respectively). The rank order of BP was in accordance with the known relative distribution of benzodiazepine receptors (Sybirska et aI. , 1992) . Values of V2 ranged from 16 ± 13 (frontal) to 23 ± 14 ml/g (occipital) . No signif icant differences were found between regions for V2 (ANOYA; region· baboon, region: p = 0.79, ba boon: p = 0.92). However, a marked variation be tween the experiments in the estimation of regional V2 was found, as attested by the high SD of the V2 regional means.
Me t hod B. Constraining V2 to the value previ ously measured at equilibrium in one baboon (16.6 mllg) (Laruelle et aI., 1993) produced convergence with AIC values similar to those obtained with the unconstrained fit. For example, in the experiment presented in Fig. 3A , AIC values were -1030, -963, and -1071 with method B in the occipital, frontal, and striatal regions, respectively, as op posed to -1038, -961, and -994 with method A, in the same regions, respectively. In the occipital and striatal regions, method A produced a signifi cantly better fit (p < 0. 01) than method B, but this was not true for the frontal region. Similar statisti cal conclusions were obtained by comparing the goodness-of-fit of methods A and B in five other experiments. The addition of one free parameter, (k 2 ), in method A improved the fit significantly in 20 of 30 curves as compared to method B.
Parameter estimates provided by method B (Ta ble 3) had lower standard errors as compared to method A. Furthermore, their values were more in accordance with physiological expectations. Values of k 3 ranged from 0. 091 ± 0.025 (thalamus) to 0. 189 ± 0.088 min -I (occipital) and their relative magni tudes (occipital> temporal = frontal> striatum = thalamus) were in accordance with the regional den sity of benzodiazepine receptors (Sybirska et aI. , 1992) . The k 3 %CY was reduced (range, 4-9%) as compared to method A (range, 15-37%). Values of k4 were virtually identical across regions and their %CY ranged from 4 to 10%.
The mean ± SD of regional V T were identical for methods A and B. Mean values of BP from methods A and B were also very close, but the SD of the mean regional BP derived by method B was slightly lower than that by method A. The higher variability of BP estimates derived with method A was related to the variability of V2 in this method, whereas V2 was constrained to a fixed value in method B. Method C. The simplification of the model to a two compartment configuration induced difficulties in the fitting process. As shown by Fig . 3B , the fitted curve underestimated the measured values at the beginning of the experiments. This lack of good ness-of-fit translated into higher AIC values com pared to those of methods A and B (AIC values for the experiment depicted in Fig . 3B were -849, -871, and -832, for occipital, frontal, and striatal regions, respectively). F-tests showed that method A was statistically superior to method C in 28 of 30 curves (p < 0.01). Vr ' showed values in relative accordance with the known distribution of benzo diazepine receptors (Table 4) , indicating that the receptor compartment is the main factor in deter mining Vr '. For every region, Vr ' values derived from method C were slightly but significantly lower (97 ± 1%) than those derived from methods A and B (ANOY A, region' fit, region: p < 0.01; fit: p < 0.01).
Relationship between total acquisition time and outcome measures. To define the minimum scan ning time required to derive stable outcome mea sures (BP for methods A and B and V T ' for method C), the occipital time activity curve of a prolonged experiment (420 min) was fit for 16 different scan ning times ranging from 0-25 to 0-420 min postin jection (Fig. 4) . At <100 min, the three outcome measures increased with longer duration of scan. At 100 min, BP values derived by methods A and B were 129 and 136%, respectively, of their final mea sured values . VT ' was not similarly overestimated and plateaued at 120 min at 103% of the value mea sured at 400 min. At 200 min, the three outcome measures were close to their final value (l05, 108, and 102% for methods A, B, and C, respectively).
Reproducibility. The reproducibility of the main outcome measure for each fitting method was as sessed by assuming that the benzodiazepine recep tor densities and affinities were unchanged between experiments 1 and 2 (Table 5 ). This assumption might not be valid for baboon 2 (202 days between experiments 1 and 2). We were interested in defin ing which factors had a significant effect on the re producibility . The following factors were consid ered: fitting strategy (methods A-C), ROI, and de lay between repeated experiments. Differences in %CY between fitting methods and between ROls were investigated with ANOY A (%CY: fit . region) . Both factors were significant. The re producibility of method A (15 ± 9%) was signifi cantly worse than those of methods B (10 ± 7%) and C (10 ± 6%) (p = 0.05). Brain areas exhibited significant differences in %CY (p < 0.01). Baboon 2 (202 days between test and retest) exhibited a poorer reproducibility across regions (16 ± 6.9%, n = 5) than did baboons 1 (21 days; 8.6 ± 7.1%, n = 5) and 3 (16 days; 10.7 ± 6.1%, n = 5). This dif ference was almost significant (A N OY A: baboon' region: baboon: p = 0.07, region: p = 0 .03) .
Comparison with in vitro values. The values of K I reported here were compatible with the physico chemical properties of iomazenil-octanol-water partition coefficient (PC) of 30 and MW of 411 (Beer et aI ., 1990) . Assuming a striatal blood flow of 0.78 ml . g -1 min -1 in the primate under anesthesia (Mintun et aI ., 1984) , Eq. 6 yielded an extraction fraction, E, of 0.85, a PS of 1.51 ml g-l min -I, and a permeability-surface area product relative to the free compound, PSF = PS/f l (Logan et aI ., 1987) of 4.54 ml g-I min -I . The PSF of iomazenil was com pared with published values of PSF for two other neuroreceptor tracers, the cholinergic antagonist IQNB and the opiate antagonist cyclofoxy, as mea sured by Sawada et ai. (1990b) . The PSF of ioma zenil (4. 54) was lower than that of the more li pophilic tracer, 3-quinuclidinyl 4-e 2 51]iodobenzi late, IQNB (PSF = 7.5, PC = 65) and higher than that of the less lipophilic tracer, cyclofoxy (PSF = 1.6, PC = 6.0). Furthermore, when plotting the re· lationship between 10g(PSF) and log(PC x MW-O.5) for all three compounds (Fig. 5) , the point corre sponding to iomazenil was close to the regression line defined by the values of IQNB and cyclofoxy (Sawada et aI., 1990b) . The average occipital benzodiazepine receptor BP was 257 ± 22 (fit B, n = 3), which was in agree ment with that derived by the equilibrium/constant infusion method in one baboon (267 ± 9, n = 2) (Laruelle et aI ., 1993) . Assuming an in vivo KD of 0.47 nM (Laruelle et aI ., 1993) , the BP value of 257 corresponded to a Bmax of 120 nM. This Bmax value is fairly similar to that measured in vitro in homoge nates of occipital cortex in baboon at 37°C (KD = 0.66 ± 0.16 nM, Bmax = 126 ± 13 nM, mean ± SD of six assays; see Laruelle et aI., 1994) .
The regional distribution of e 23 I]iomazenil bind ing in primates was studied with in vitro autoradi ography (Sybirska et aI ., 1992) . The total binding in temporal, frontal, striatal, and thalamic areas, ex pressed as % of occipital cortex, was 80 ± 5, 80 ± 7, 49 ± 12, and 47 ± 9%, respectively (n = 3). A similar distribution was found in cortical homoge nate membranes of baboon (temporal, 78 ± 1; fron tal, 78 ± 5; n = 2) (see Laruelle et aI ., 1994) . The relative regional values of in vivo BPs measured in these studies was temporal, 66 ± 7%; frontal, 65 ± 6%; striatum, 44 ± 7%; and thalamus, 44 ± 6% . Temporal and frontal BPs were underestimated . This is apparent from Fig. 6 , which presents the plot of relative autoradiography values versus relative BP values. The straight line represents the ideal 10cation of each point in case of a perfect correlation between the measured in vitro and in vivo data. The apparent underestimation of temporal and frontal BPs relative to that of occipital may be due to par tial volume effects, since the occipital lobe in ba boon is much larger and more densely packed with gray matter than either the temporal or frontal lobes (Riche et aI., 1988) . The partial voluming effect was not apparent in striatum and thalamus, presumably because of partial compensation due to contamina tion of these relatively cold ROls by blurred and J Cereb Blood Flow Metab, Vol. 14, No.3, 1994 scattered activities originating in the relatively hot cortical ring .
Equilibrium analysis
Transient equilibrium analysis. The apparent re gional volume of distribution, V a ( t ) , did not reach constant values within the time frame of the exper iment. In the experiment depicted in Fig. 7 A, V a ( t ) values at the end of the experiment (300 min) were 548, 372, and 187 mllg in occipital, frontal, and stri atal regions, respectively . These values were much higher than those of the equilibrium distribution volumes derived from method C (271, 187, and 120 mllg for occipital, frontal, and striatal regions, re spectively). Hence, the transient equilibrium anal ysis was not applicable to these experiments.
Peak uptake equilibrium analysis. The regional time activity curves plateaued between 30 and 120 min, but failed to exhibit sharp and visually identi fiable peaks. To circumvent this difficulty, the peak time identified by the three-compartment fit (method B) was chosen to calculate Vp k ' For exam ple, in the experiment depicted in Fig. 7B , the high est occipital value derived from method B was ob tained at 94 min postinjection. At that time, Va(t) was 270 mllg, a value very close to the VT value estimated from method C (271 mg/g). The mean ± SD regional Vpk values (occipital, 249 ± 25; tempo ral, 164 ± 19; frontal, 163 ± 17; striatal, 103 ± 18; and thalamus, 103 ± 15 mllg; n = 6, Table 6 ) were virtually identical to regional V T ' values derived from the kinetic analysis according to method C.
Peak time (min), peak activity (f-.LCi/ml), and peak distribution volume for each baboon and each re gion were compared (ANOYA, baboon x region; Table 6 ). For peak time, both factors were signifi cant (region, p < 0.01; baboon, p < 0.01). ·Baboon 1 had a significantly earlier mean regional peak time (60 ± 13 min, n = 10) than did baboons 2 (82 ± 23 min, n = 10) and 3 (76.5 ± 18 min, n = 10). For three-compartment model k3 CV k4 k4 CV (%) (min -I) (%) 28 ± 30 0. 0140 ± 0.009 1 14 ± 15 27 ± 32 0. 0153 ± 0.0075 13 ± 18 37 ± 32 0. 0148 ± 0.0089 17 ± 15 15 ± 6 0. 0160 ± 0.0060 5 ± 2 18 ± 8 0. 0157 ± 0.0058 6 ± 3 7 ± 6 0.0130 ± 0.006 1 7 ± 6 6±6 0. 0162 ± 0.0080 7 ± 6 9±6 0. 0160 ± 0.0060 10 ± 5 4 ± 1 0. 0162 ± 0.0044 4 ± 1 5 ± 2 0. 0158 ± 0.0048 5 ± I peak activity, both factors were also significant (re gion, p < 0.01; baboon, p < 0.01). Baboon 1 showed significantly lower peak activity (mean ± SD peak activity of all regions, 7.3 ± 1.2 f.LCi/ml, n = 10) than did baboons 2 (9.1 ± 2.1 f.LCi/ml, n = 10) and 3 (8.77 ± 2.3 f.LCi/ml, n = 10). Yet, there was no statistically significant difference between baboons in Vp k (region, p < 0.01; baboon, p = 0.933), indi cating that these differences were not related to lower receptor density in baboon 1. Differences in peak times and peak activities between baboons were caused by differences in tracer peripheral clearance ( Table 2) .
Simulations
The derivation of the kinetic rate constants al lowed evaluation of the validity of a typical empir ical method based on the total counts recorded in a single prolonged acquisition. We simulated tempo ral lobe time activity curves at various values of Bm a x with all other parameters kept constant. Model parameters derived from the temporal lobe in a typical experiment were used: fl' 0.333; Vbol ' 6.87 L; fOI' 0.934; f0 2 ' 0.188; f0 3 ' 0.0548; A I ' 1.03 min -I, A 2 ' 0.0447 min -I, A 3 ' 0.00396 min -I; Cv 21.7 LIh; K I , 0.855 ml . g-I min -I; K/k 2 ratio, 5.51; k 3 , 0.108 min -I; k4' 0.0107 min -I; and BP, 166. Bm a x changes were implemented by setting k 3 at 12.5, 25, 50, 75, 100, 150, 200, 300 , and 400% of the control value. The empirical outcome measure was the ratio of counts in the "affected" region to counts in the "contralateral" (control) region, re corded between 50 and 100 min post injection.
Simulated and control curves are shown in Fig. 8 . The relationship between Bm a x ratios and count ra tios was not linear over the entire range of simu lated changes. Within a limited range (± 50%), this relationship could be approximated by a straight line with a slope of 0.59 and an intercept of 0.34. In other terms, and within that range, a Bm a x change of ± 1 will translate into a change in counts ratio of ±0.59.
DISCUSSION
The aim of this study was to evaluate the feasi bility and reproducibility of the benzodiazepine re ceptor BP quantification with SPECT, after a single bolus injection of e 23 I]iomazenii. Various kinetic models and equilibrium approaches were evaluated . To our knowledge, this is the first report of this type of model-based analysis applied to SPECT mea surement of uptake of central neurotransmitter re ceptor probes. As an increasing number of SPECT receptor probes are available for clinical studies, it is important to apply to SPECT data analysis the same rigor as previously developed for PET studies.
Kinetic analysis.
The three-compartment kinetic model, whether constrained or unconstrained, provided excellent determination of V T ' Some difficulties were noted for proper derivation of the four kinetic parameters and the BP in the unconstrained model. These dif ficulties were solved by fixing V 2 • The difficulty of obtaining four reliable parameter estimates from an unconstrained three-compartment fit has been fre quently reported in the PET literature (Frost et al., 1989; Sadzot et aI ., 1991; Carson et aI., 1992) Considering that the receptor compartment con tributed 85-95% of VT , variations in VT are more likely to reflect variations in receptor numbers than nonspecific binding. Thus, VT appears to be a valu able outcome measure for clinical studies, as it is not biased by potential between subject differences in blood flow or peripheral clearance.
A similar reasoning led Koeppe et al. (Koeppe et ai ., 1991) to propose a two-compartment kinetic analysis of [IIC] flumazenil PET experiments. One reported advantage of a two-versus a three compartment configuration for [11C]flumazenil was that stable estimates could be obtained within a shorter experimental time (Koeppe et al., 1991) . This potential advantage was only marginally true for e 23 1]iomazenil (Fig. 4) . Furthermore, the three compartment fit was significantly better than the two-compartment fit. This simplified configuration does not appear to be the method of choice for [1 23 1]iomazenil, presumably due to the longer time needed for equilibration of e 23 I]iomazenil as com pared to that for [ l 1C]flumazenil. At least 200 min of data acquisition were needed to provide stable outcome measures in the occipital region, the area that showed the latest time of peak activity. This prolonged acquisition time is obvi ously of major concern for human studies. How ever, the peripheral clearance of e 23 I]iomazenil in humans is faster (7. 4 ± 1.0 Llh x kg, n = 7) (un published data) than that in anesthetized baboons (2.1 ± 0.5 Llh x kg). The average occipital peak time for e 23 I]iomazenil in humans is 30 ± 8 min, (n 5) (Woods et al., 1992) , with other regions peak- Yalues are mean % CY of the outcome measure fr om three pairs of test/retest . Outcome measures were BP for methods A and B, and V T for method C. a Significant differences in reproducibility (ANOY A, method · region ; method, p = 0.05, region , p < 0.0 1).
ing earlier. Based on this, shorter experiments are expected to be adequate to provide stable outcome measures in humans.
The reproducibility of the kinetic method was in fluenced by the fitting strategy, the region, and the test/retest interval . The overall %CY (mean of all methods for all regions in all pairs) was 12 ± 3%, which indicates that the measures were located at ±8% of the mean. The two-compartment and the constrained three-compartment models (both of which actually measure V T, not BP) provided sig nificantly better reproducibility (10 ± 6 and 10 ± 7%, respectively, n = 15) than did the uncon strained three-compartment model (15 ± 9%). Thus, VT was estimated with a %CY of 10%. The Relationship between the permeability-surface area product relative to the free tracer as measured in vivo, log (PS F), and as predicted by physico-chemical properties, log(PC*MW -05), where PC is the octanol·water partition co· efficient and MW is the molecular weight. Data from the li pophilic muscarinic antagonist, IONB and the less lipophilic opiate antagonist, cyclofoxy, are taken from Sawada et ai. (1990) . PS F value of iomazenil (4.54 ml . g-1 min-1) was cal culated according to Eq. 6, using the average striatal K 1 (0.668 mi · g-1 min-1 ) and ' 1 (0.333) measured in these stud· ies and assu ming a striatal blood flow of 0.78 mi · g-1 min-1 (Mintun et ai., 1984) . As illustrated by the figure, iomazenil measured PS F value was in close agreement with that pre dicted from its physico-chemical properties and by the re gression line between I-ONB and cyclofoxy published values. In vitro autoradiography (% occipital)
FIG. 6. Relationship between the mean regional in vivo [1 2 3lJlomazenil BP derived from SPECT experiments (n = 6, method B) performed in three baboons and the regional in vitro [1 2 3lJ iomazenil total binding measured by autoradiogra phy in three vervet monkey brains (Sybirska et ai., 1992) .
Values are expressed in % occipital region. The solid line represents the ideal location of the points if relative SPECT BP and relative autoradiographic values were linearly related with a slope of 1. The r2 of the regression was 0.90, indicating a significant linear correlation. However, SPECT BP relative values of the frontal and temporal ROls were lower (-80%) than those predicted by autoradiography, presumably due to partial volume effects.
additional "cost" in variability for estimating BP without a constraint on V 2 can be approximated at 5%.
Equilibrium analysis
Transient equilibrium analysis could not be ap plied to these experiments, since V a ( t ) increased in all regions during the time frame of the experiment. A transient equilibrium occurs when the brain washout rate is faster than that of the plasma clear ance (Patlak et aI ., 1983) . The brain regional wash out rate, as evaluated by k 2 ' , ranged from 0. 0059 ± 0.0003 (occipital region) to 0.0094 ± 0.0018 min -I (striatum). These values were comparable to the terminal half-life of the peripheral clearance (A 3 ' 0.0064 ± 0.0024 min -I ). Thus, a transient equilib rium state was not observed during the time frame of these experiments. Carson et al. (1992) recently demonstrated that the transient equilibrium method overestimates the BP unless the brain washout (as estimated by k 2 ' or al) is much faster than A 3 ' In deed, at 300 min, the value of V a ( t ) was higher than that of VT . Thus, even if longer experimental times had allowed attainment of a transient equilibrium state in regions such as the striatum, this analysis would have overestimated VT • The peak equilibrium method is superior to the transient equilibrium method, at least theoretically,. if the peak uptake can be correctly identified. Using the peak time as defined by kinetic analysis, calcu lated Vp k values were similar to VT values derived '3 oe FIG. 7. Transient and peak equilibrium analyses. A: Tran sient equilibrium analysis. Apparent volume of distribution, Va(t) , in occipital, frontal and striatal regions. Va(t) was cal culated by dividing the fitted ROI values (method B) by the input function values from the experiment depicted in Fig. 3 . Va(t) increased during the study and did not reach a constant value. Therefore, the transient equilibrium method could not be applied to these data. B: Peak equilibrium analysis. Mea sured (circles) and fitted (solid line, method B) occip ital time activity curves and corresponding Va(t) (dashed line). This figure illustrates the observation that Va(t) at peak ROI uptake (94 min, 12.2 jJ-Ci/ml) is equal to the total equilibrium volume of distribution of the tissue, V 2 ', 270 ml/g. J Cereb Blood Flow Me/ab, Vol. 14, No. 3, 1994 compartmental fitting, was problematic, which lim its the practical value of the method.
Empirical methods
Model-based methods may be difficult to imple ment in routine clinical settings. Thus, evaluation of empirical methods that do not require plasma mea surements are of considerable clinical interest. The relationship between an empirical counts ratio and the "true" Bm a x ratio was explored by simulations, assuming other factors to be unchanged (similar blood flow and nonspecific binding). We found this relationship was linear with a slope far from unity (0.59) for a limited range (±50%) of Bm a x alter ations. Given that changes in blood flow may be present in clinical conditions associated with changes in benzodiazepine receptor density (for ex ample, temporal lobe epilepsy) and may introduce Changes in Bmax were simulated by changing k3 to 12.5, 25, 50, 75, 150, 200, 300 , and 400% of the k3 control values while all other parameters were kept constant. The figure reveals that peak uptake occurs later when the receptor density in creases. This simulation allowed estimation of the error in troduced by an empirical method using the count rate at a fixed time to estimate regional benzodiazepine density.
further bias in the measurement, empirical ratio methods should be used with caution. Comparison between individuals using empirical methods can be further obscured by differences in peripheral clearance. No simulations were needed to demonstrate this effect. Baboon 1 showed signif icantly earlier and smaller peak uptake in all regions than did baboons 2 or 3. The observation of these differences by empirical methods can be misinter preted as being differences in benzodiazepine re ceptor densities. However, these differences re solved when the data were corrected for plasma clearance with a model-based method as simple as the peak equilibrium method.
In conclusion, these studies suggest that the re gional e 23 I]iomazenil VT can be measured by SPECT with kinetic modeling analysis. This mea sure is reproducible, in excellent agreement with in vitro values, and protected from potential between subject differences in flow or plasma clearance. Two limitations of the method must be noted: (a) this method does not correct for potential differ ences in nonspecific binding, which is not too prob lematic with e 23 I]iomazenil, since nonspecific bind ing represents only a minor fraction of the total vol ume of distribution and (b) this method requires multiple scans, which decreases the compliance of subjects, multiple blood sampling, and analyses, all of which are time consuming. The latter limitation, as well as the limitation of equilibrium analysis after single bolus injection, prompted us to develop the constant infusion paradigm and sustained equilib rium method described in Laruelle et al. (1994) .
